Pacira BioSciences, Inc. (PCRX) — Cash Flow Reinvestment Rate
Pacira BioSciences, Inc. (PCRX) has a Cash Flow Reinvestment Rate of 0.98x as of March 2026, reinvesting $25.22 Million (capex $2.72 Million plus investments $22.50 Million) from operating cash flow of $25.68 Million. Check Pacira BioSciences, Inc. cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Pacira BioSciences, Inc. Cash Flow Reinvestment Rate (2014–2025)
Historical reinvestment intensity for Pacira BioSciences, Inc. across 12 annual periods. Explore PCRX long-term investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Pacira BioSciences, Inc. (2014–2025)
Year-by-year capital reinvestment analysis for Pacira BioSciences, Inc.. For live market cap and broader valuation context, see market value of Pacira BioSciences, Inc..
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.97x | $146.85 Million | $151.99 Million | $15.33 Million | ▲ +94.8% |
| 2024 | 0.50x | $93.91 Million | $189.39 Million | $10.64 Million | ▼ -19.7% |
| 2023 | 0.62x | $95.52 Million | $154.65 Million | $15.16 Million | ▼ -64.8% |
| 2022 | 1.76x | $255.26 Million | $145.27 Million | $30.08 Million | ▼ -55.4% |
| 2021 | 3.94x | $494.98 Million | $125.72 Million | $45.87 Million | ▲ +9.3% |
| 2020 | 3.60x | $277.61 Million | $77.03 Million | $37.80 Million | ▲ +2180.7% |
| 2019 | 0.16x | $11.14 Million | $70.52 Million | $10.16 Million | ▼ -86.3% |
| 2018 | 1.16x | $56.45 Million | $48.87 Million | $14.51 Million | ▼ -89.7% |
| 2017 | 11.26x | $200.31 Million | $17.79 Million | $19.27 Million | ▲ +720.9% |
| 2016 | 1.37x | $45.90 Million | $33.45 Million | $24.71 Million | ▼ -42.7% |
| 2015 | 2.39x | $69.43 Million | $29.00 Million | $41.27 Million | ▼ -42.4% |
| 2014 | 4.16x | $105.91 Million | $25.47 Million | $21.89 Million | — |